Community Academic Profiles

Teri A Longacre

Publication Details

  • Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

    Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D. Gynecol Oncol. 2006; 100 (2): 264-70

    Amplification of the 11q13 locus is commonly observed in a number of human cancers including both breast and ovarian cancer. Cyclin D1 and EMS1 have been implicated as candidate oncogenes involved in the emergence of amplification at this locus. Detailed analysis of the 11q13 amplicon in breast cancer led to the discovery of four regions of amplification suggesting the involvement of other genes. Here, we investigate the role of EMSY, a recently described BRCA2 interacting protein, as a key element of the 11q13 amplicon in ovarian cancer. EMSY maps to 11q13.5 and is amplified in 13% of breast and 17% of ovarian carcinomas.

    PubMedID: 16236351

Stanford Medicine Resources:

Footer Links: